Pituitary incidentalomas

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 1, 2000, Pages 205-221

  Aron, David C ^a,b   Howlett, Trevor A ^c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; DEXAMETHASONE; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; SOMATOMEDIN C;

ACROMEGALY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; HYPOPITUITARISM; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR DIAGNOSIS;

EID: 0034059520     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70124-9     Document Type: Article

References (101)

1. L. Alexander D. Appleton R. Hall Epidemiology of acromegaly in the Newcastle region Clin Endocrinol 12 1980 71 79
2. B. Ambrosi G. Faglia Multicenter Pituitary Tumor Study Group Lombardia region: Epidemiology of pituitary tumors G. Faglia Pituitary Adenomas: New Trends in Basic and Clinical Research 1991 Elsevier Science New York 159 168
3. B. Ambrosi S. Peverelli E. Passini Abnormalities of endocrine function in patients with clinically “silent” adrenal masses Eur J Endocrinol 132 1995 422 428
4. J.F. Annegers C.B. Coulam C.P. Abboud Pituitary adenoma in Olmstead County, Minnesota, 1935–1977: A report of an increasing incidence of diagnosis in women of childbearing age Mayo Clin Proc 53 1978 641 643
5. APA Task Force on Laboratory Tests in Psychiatry The dexamethasone suppression test: An overview of its current status in psychiatry Am J Psychiatry 14 1987 1253 1262
6. G.W. Arana S. Reichlin R. Workman The dexamethasone suppression index: Enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone Am J Psychiatry 145 1988 707 711
7. D.C. Aron Hormonal screening in the patient with an incidentally discovered pituitary mass: Current practice and factors in clinical decision making Endocrinologist 5 1995 357 363
8. D.C. Aron J.B. Tyrrell Cushing's syndrome Endocrinol Clin North Am 23 1994 451 691
9. D.C. Aron J.B. Tyrrell C.B. Wilson Pituitary tumors: Current concepts in diagnosis and management West J Med 162 1995 340 352
10. X. Badia A. Lucas A. Sanmaritit One-year follow-up of quality of life in adults with untreated growth hormone deficiency Clin Endocrinol 49 1998 765 771
11. A.L. Barkan Acromegaly Endocrinol Clin North Am 18 1989 277 310
12. J.H. Barth J. Seth T.A. Howlett A survey of endocrine function testing by clinical biochemistry laboratories in the UK Ann Clin Biochem 32 1995 442 449
13. B.A. Bengtsson S. Eden L. Lonn Treatment of adults with growth hormone (GH) deficiency with recombinant human GH J Clin Endocrinol Metab 76 1993 309 317
14. B.A. Bengtsson S. Eden I. Ernest Epidemiology and long-term survival in acromegaly Acta Med Scand 223 1988 327 335
15. B.M.K. Biller H.B.A. Baum D.I. Rosenthal Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea J Clin Endocrinol Metab 75 1992 692 697
16. W.C. Black H.G. Welch Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy N Engl J Med 328 1993 1237 1243
17. G.N. Burrows G. Wortzman N.B. Rewcastle Microadenomas of the pituitary and abnormal sella tomograms in an unselected autopsy series N Engl J Med 304 1981 156 158
18. P.V. Carroll E.R. Christ B.A. Bengtsson Growth hormone deficiency in adulthood and the effects of growth replacement: A review. Growth Hormone Research Society Scientific Committee J Clin Endocrinol Metab 83 1998 382 395
19. A.G. Chacko M.J. Chandy Incidental pituitary macroadenomas Br J Neurosurg 6 1992 233 236
20. E.F. Chambers P.A. Turski D. LaMasters Regions of low density in the contrast-enhanced pituitary gland: Normal and pathologic processes Radiology 144 1982 109 113
21. B.M. Chang-DeMoranville M.D. Jackson Diagnosis and endocrine testing in acromegaly Endocrinol Metab Clin North Am 21 1992 649 668
22. R.M. Chidiac D.C. Aron Incidentalomas: A disease of modern technology Endocrinol Metab Clin North Am 26 1997 233 253
23. B.W. Chong W. Kucharaczyk W. Singer Pituitary gland MR: A comparative study of healthy volunteers and patients with microadenomas AJNR Am J Neuroradiol 15 1994 675 679
24. D.R. Clemmons J.J. VanWyk E.C. Ridgway Evaluation of acromegaly by radioimmunoassay of somatomedin-C N Engl J Med 301 1979 1138 1142
25. A. Colao R. Pivonello S. Spiezia Persistence of increased cardiovascular risk with Cushing's disease after five years of successful cure J Clin Endocrinol Metab 84 1999 2664 2672
26. L. Crapo Cushing's syndrome: A review of diagnostic tests Metabolism 28 1979 955 977
27. R.C. Cuneo S. Judd J. Wallace The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults J Clin Endocrinol Metab 83 1998 107 116
28. L. Daneshdoost T.A. Gennarelli H.M. Bashey Recognition of gonadotroph adenomas in women N Engl J Med 324 1991 589 594
29. L. Daneshdoost T.A. Gennarelli H.M. Bashey Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone subunit response to thyrotropin-releasing hormone J Clin Endocrinol Metab 77 1993 1352 1355
30. M.J. Davies T.A. Howlett A survey of the current methods used in the UK to assess pituitary function J R Soc Med 89 1996 159P 164P
31. H. Demura R. Takeda I. Miyamori Cushing's syndrome in Japan with special reference to adrenocortical nodular dysplasia or hyperplasia R. Takeda Controversies in Disorders of Adrenal Hormones: Proceedings of the Open Symposium of Disorders of Adrenal Hormones, Tokyo, Japan, 1988 1988 Excerpta Medica Amsterdam 3 25
32. L.E. Donovan B. Corenblum The natural history of the pituitary incidentaloma Arch Intern Med 155 1995 181 183
33. E. Duncan J.A.H. Wass Investigation protocol: Acromegaly and its investigation Clin Endocrinol 50 1999 285 293
34. J.M. Eisenberg Doctors' Decisions and the Cost of Medical Care 1986 Health Administration Press Ann Arbor, MI
35. A.D. Elster Modern imaging of the pituitary Radiology 187 1993 1 14
36. J. Extabe J.A. Vazquez Morbidity and mortality in Cushing's disease: An epidemiological approach Clin Endocrinol 40 1994 479 484
37. S.M.S. Ezzat Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 72 1991 245 249
38. J. Feldkamp R. Santen E. Harms Incidentally discovered pituitary lesions: High frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study Clin Endocrinol 51 1999 109 113
39. P.U. Freda K.D. Post Differential diagnosis of sellar masses Endocrinol Metab Clin North Am 28 1999 81 118
40. E.B. Gold Epidemiology of pituitary adenomas Epidemiol Rev 3 1981 163 183
41. W.A. Hall M.G. Luciano J.L. Doppman Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population Ann Intern Med 120 1994 817 820
42. P.E. Harlberg G.E. Sheline Radiotherapy of pituitary tumors Endocrinol Clin North Am 16 1987 667 684
43. Howlett TA, Aron DC: Management of `pituitary incidentalomas': A survey of UK endocrinologists [abstract]. In Program of 80th Annual Meeting of the Endocrinology Society, New Orleans, LA, June 24th–27th, 1998
44. P.J. Jenkins G.M. Besser Colorectal neoplasia in acromegaly Gut 44 1999 585 587
45. M.R. Johnson R.D. Hoare T. Cox The evaluation of patients with suspected pituitary microadenoma: Computer tomography compared to magnetic resonance imaging Clin Endocrinol 36 1992 335 338
46. J.P. Kassirer Our stubborn quest for diagnostic certainty: A cause of excessive testing N Engl J Med 320 1989 1489 1491
47. G.L. Katzman A.P. Dagher N.J. Patronas Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers JAMA 282 1999 36 39
48. L. Katznelson J.M. Alexander A. Klibanski Clinically nonfunctioning pituitary adenomas J Clin Endocrinol Metab 76 1993 1089 1094
49. T.B. Kaye L. Crapo The Cushing syndrome: An update on diagnostic tests Ann Intern Med 112 1990 434 444
50. J.T. King Jr A. Justice D.C. Aron Management of incidental pituitary macroadenomas: A cost-effectiveness analysis J Clin Endocrinol Metab 82 1997 3625 3632
51. A. Klibanski N.T. Zervas Diagnosis and management of hormone-secreting pituitary adenomas N Engl J Med 324 1991 822 831
52. A. Klibanski N.T. Zervas K. Kovacs Clinically silent hypersecretion of growth hormone in patients with pituitary tumors J Neurosurg 66 1987 806 811
53. M.H. Laudat S. Cerdas O. Fournier Salivary cortisol measurement: A practical approach to assess pituitary-adrenal function J Clin Endocrinol Metab 66 1988 343 348
54. A. Laupacis Preventive therapies: Weighing the pros and cons Can Med Assoc J 154 1996 1510 1512
55. E.R. Laws Jr K. Thapar Pituitary surgery Endocrinol Metab Clin North Am 28 1999 119
56. V. Leite H. Cosby L.G. Sobrinho Characterization of big, big prolactin in patients with hyperprolactinaemia Clin Endocrinol 37 1992 365 372
57. D. LeRoith D. Clemmons P. Nissley NIH conference: Insulin-like growth factors in health and disease Ann Intern Med 116 1992 854 862
58. K.G. Marshall Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits Can Med Assoc J 154 1996 1493 1499
59. K.G. Marshall Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits Can Med Assoc J 154 1996 1837 1843
60. K.G. Marshall Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm Can Med Assoc J 155 1996 169 175
61. S. Melmed Acromegaly N Engl J Med 322 1990 966 976
62. T. Mindermann C.B. Wilson Thyrotropin-producing pituitary adenomas J Neurosurg 79 1993 521 527
63. K. Miyai K. Icinhare K. Kondo Asymptomatic hyperprolactinaemia and prolactinaemia in the general population: Mass screening by paired assays of serum prolactin Clin Endocrinol 25 1986 549 554
64. A. Miyake M. Ikegami C.F. Chen Mass screening for hyperprolactinemia and prolactinoma in men J Endocrinol Invest 11 1988 383 384
65. J.W. Mold H.F. Stein The cascade effect in the clinical care of patients N Engl J Med 314 1986 512 514
66. M.E. Molitch Clinical manifestations of acromegaly Endocrinol Metab Clin North Am 21 1992 597 614
67. M.E. Molitch Evaluation and treatment of the patient with a pituitary incidentaloma J Clin Endocrinol Metab 80 1995 3 6
68. M.E. Molitch Prolactinoma S. Melmed The Pituitary 1995 Blackwell Science Cambridge, MA 443 477
69. M.E. Molitch E.J. Russell The pituitary “incidentaloma” Ann Intern Med 112 1990 925 931
70. M. Monreal E. Lafoz M. Foz Occult thyrotoxicosis in patients with atrial fibrillation and an acute arterial embolism Angiology 39 1988 981 985
71. C. Muhr K. Bergstrom L. Grimelius A parallel study of the roentgen anatomy of the sella turcica and the histopathology of the pituitary gland in 205 autopsy specimens Neuroradiology 21 1981 55 65
72. M.J. Naidich E.J. Russell Current approaches to imaging of the sellar region and pituitary Endocrinol Metab Clin North Am 28 1999 45 80
73. G.M. Nammour J. Ybarra M.H. Naheedy Incidental pituitary macroadenomas: A population based study Am J Med Sci 314 1997 287 291
74. J. Newell-Price P. Trainer L. Perry A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome Clin Endocrinol 43 1995 545 550
75. Nieman LK, Cutler GB: The sensitivity of the urine free cortisol measurement as a screening test for Cushing's syndrome [abstract]. In Program of the 72nd Annual Meeting of the Endocrinology Society, Atlanta, GA, 1990
76. G. Osella M. Terzolo A. Piovesan Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas J Clin Endocrinol Metab 82 1997 3303 3307
77. Papanicolaou DA, Yanovski JA, Cutler GB, et al: A single midnight cortisol measurement discriminates Cushing syndrome from pseudo-Cushing states [abstract]. In Program of the 76th Annual Meeting of the Endocrinology Society, Anaheim, CA, June 15th–18th, 1994
78. V. Popovic S. Damjanovic D. Micic Pituitary Study Group Increased incidence of neoplasia in patients with pituitary adenomas Clin Endocrinol 49 1998 441 445
79. K. Radhakrishnan B. Mokin J.E. Paris The trends in incidence of primary brain tumors in the population of Rochester, Minnesota Ann Neurol 37 1995 67 73
80. H. Raff J.L. Raff J.W. Findling Late-night salivary cortisol as a screening test for Cushing's syndrome J Clin Endocrinol Metab 83 1998 2681 2686
81. R.V. Randall E.R. Laws Jr C.F. Abboud Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: Results in 100 patients Mayo Clin Proc 58 1983 108 121
82. D.F. Ransohoff A.R. Feinstein Problems of spectrum and bias in evaluating the efficacy of diagnostic tests N Engl J Med 299 1978 926 930
83. M. Reincke B. Allolio W. Saeger The `incidentaloma' of the pituitary gland: Is neurosurgery required? JAMA 263 1990 2772 2776
84. F. Roelfsma M. Frolich H. Van Dulken Somatomedin-C levels in treated and untreated patients with acromegaly Clin Endocrinol 26 1987 137 144
85. J. Schlechte K. Dolan B. Sherman The natural history of untreated hyperprolactinemia: A prospective analysis J Clin Endocrinol Metab 68 1989 412 418
86. J. Schlechte L. Walkner M. Kathol A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia J Clin Endocrinol Metab 75 1992 698 702
87. K.K. Shy A.M. McTiernan J.R. Daling Oral contraceptive use and the occurrence of pituitary prolactinoma JAMA 249 1983 2204 2207
88. S.G. Soule H.S. Jacobs The evaluation and management of subclinical pituitary disease Postgrad Med J 72 1996 258 262
89. H.C. Sox Jr M.A. Blatt M.C. Higgins Measuring the accuracy of clinical data Medical Decision Making 1988 Butterworth-Heinemann Boston 103 145
90. G.M. Stall S. Harris L.J. Sokoll Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine Ann Intern Med 113 1990 265 269
91. B. Swearingen B.M.K. Biller F.G. Barker II Long-term mortality after transsphenoidal surgery for Cushing disease Ann Intern Med 130 1999 824
92. E. Tenner Why Things Bite Back: Technology and the Revenge of Unintended Consequences 1996 AA Knopf New York
93. M. Terzolo G. Tappero G. Borretta High prevalence of colonic polyps in patients with acromegaly: Influence of sex and age Arch Intern Med 154 1994 1272 1276
94. S. Tsagarakis C. Roboti P. Kokkoris Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations in the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas Clin Endocrinol 49 1998 165 171
95. K.H. Tseng P.G. Walfish J.A. Persaud Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status J Clin Endocrinol Metab 69 1989 633 638
96. US Preventive Services Task Force Guide to Clinical Preventive Services 1996 Williams & Wilkins Baltimore, MD
97. J.I. Westbrook J. Braithwaite J.H. McIntosh The outcomes for patients with incidental lesions: Serendipitous or iatrogenic? AJR Am J Roentgenol 171 1998 1193 1196
98. C.B. Wilson Endocrine-inactive pituitary adenomas Clin Neurosurg 38 1992 10 31
99. S.H. Woolf D.B. Kamerow Testing for uncommon conditions: The heroic search for positive results Arch Intern Med 150 1990 2451 2458
100. J.A. Yanovski G.B. Cutler Jr G.P. Chrousos Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: A new text to distinguish Cushing's syndrome from pseudo-Cushing's state JAMA 269 1993 2232 2238
101. N.C. Yue W.T. Longstreth Jr A.D. Elster Clinically serious abnormalities found incidentally at MR imaging of the brain: Data from the Cardiovascular Health Study Radiology 202 1997 41 46